ORGANOGENESIS HOLDINGS INC. - CLASS A

Organogenesis Appoints Jon Giacomin to Board of Directors

10 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting

06 май 2021 17:23:02 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021

12 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

16 мар 2021 16:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Appoints David C. Francisco as Chief Financial Officer

16 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March

09 фев 2021 16:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021

08 фев 2021 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis

14 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020

13 янв 2021 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee

11 янв 2021 09:01:30 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the ICR Conference 2021

05 янв 2021 16:05:00 Источник Nasdaq GlobeNewswire